X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Indrayani Biotech Ltd.
BSE CODE: 526445   |   NSE CODE: NA   |   ISIN CODE : INE007C01021   |   12-May-2026 Hrs IST
BSE NSE
Rs. 10.85
-0.36 ( -3.21% )
 
Prev Close ( Rs.)
11.21
Open ( Rs.)
11.25
 
High ( Rs.)
11.28
Low ( Rs.)
10.71
 
Volume
29527
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs.
( )
 
Prev Close ( Rs.)
Open ( Rs.)
 
High ( Rs.)
Low ( Rs.)
 
Volume
Week Avg.Volume
NA
 
52 WK High-Low Range(Rs.)
Particulars Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operational & Financial Ratios          
   Earnings Per Share (Rs)0.32  0.32  1.48  1.23  -3.18  
   CEPS(Rs)0.59  0.70  1.92  1.46  -3.36  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)11.39  11.07  11.79  7.06  5.83  
   Tax Rate(%)-123.78  51.57  0.44  0.00  0.00  
Margin Ratios          
   Core EBITDA Margin(%)14.71  9.31  11.71  10.76  -22.22  
   EBIT Margin(%)21.30  12.79  10.64  10.55  -42.45  
   Pre Tax Margin(%)1.71  4.83  6.82  7.29  -51.82  
   PAT Margin (%)3.83  2.34  6.79  7.29  -51.82  
   Cash Profit Margin (%)6.54  4.66  8.04  7.88  -49.91  
Performance Ratios          
   ROA(%)1.13  1.29  6.75  9.47  -54.34  
   ROE(%)2.83  3.21  15.67  19.15  -114.06  
   ROCE(%)6.99  7.99  12.45  16.03  -50.65  
   Asset Turnover(x)0.29  0.55  0.99  1.30  1.05  
   Sales/Fixed Asset(x)1.63  2.38  3.42  3.45  1.27  
   Working Capital/Sales(x)1.97  3.12  4.58  -124.20  -7.79  
Efficiency Ratios          
   Fixed Capital/Sales(x)0.61  0.42  0.29  0.29  0.79  
   Receivable days164.55  99.04  71.31  55.53  42.09  
   Inventory Days17.44  11.09  7.91  7.71  18.83  
   Payable days139.24  22.26  35.25  45.36  44.01  
Valuation Parameters          
   PER(x)40.96  140.17  34.90  22.54  0.00  
   PCE(x)23.97  70.32  29.46  20.84  -1.89  
   Price/Book(x)1.14  4.05  4.37  3.94  0.99  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)3.35  4.53  3.19  2.06  1.74  
   EV/Core EBITDA(x)13.95  29.96  25.35  18.53  -8.30  
   EV/EBIT(x)15.73  35.40  29.93  19.57  -4.10  
   EV/CE(x)1.08  2.50  2.75  2.93  1.03  
   M Cap / Sales1.72  3.59  2.60  1.80  1.03  
Growth Ratio          
   Net Sales Growth(%)-39.40  -16.32  28.44  176.04  4086.31  
   Core EBITDA Growth(%)-3.71  0.63  44.89  246.66  -2747.04  
   EBIT Growth(%)0.92  0.55  29.63  168.59  -5663.44  
   PAT Growth(%)-0.76  -71.18  19.67  138.81  -5197.06  
   EPS Growth(%)-0.76  -78.34  19.67  138.82  -463.93  
Financial Stability Ratios          
   Total Debt/Equity(x)1.19  1.16  0.71  0.69  0.77  
   Current Ratio(x)1.31  1.39  1.49  0.97  0.77  
   Quick Ratio(x)1.28  1.35  1.44  0.90  0.68  
   Interest Cover(x)1.09  1.61  2.78  3.24  -4.53  
   Total Debt/Mcap(x)0.95  0.26  0.18  0.16  0.71